Report Overview
Lurasidone is an atypical antipsychotic medication used in the treatment of schizophrenia and bipolar depression. It works by helping to restore the balance of certain natural substances in the brain. In terms of market positioning, Lurasidone competes in the broader antipsychotic drug market, which is characterized by a range of medications targeting various mental health conditions.
As of 2023, the global market size for Lurasidone stands at approximately USD 350 million. Looking ahead, the market is expected to grow at a Compound Annual Growth Rate (CAGR) of 5.75% from 2024 to 2032. This growth can be attributed to several key drivers and market forces. Firstly, the increasing prevalence of mental health disorders worldwide is driving the demand for effective antipsychotic medications like Lurasidone. Additionally, advancements in healthcare infrastructure and growing awareness about mental health treatments are further propelling market growth.
One notable trend in the Lurasidone market is the rising adoption of telepsychiatry services. With the increasing use of telemedicine platforms, patients have greater access to mental health professionals who can prescribe medications like Lurasidone. This trend is particularly prominent in regions where access to healthcare services is limited. Another trend is the focus on developing extended-release formulations of Lurasidone, which can improve patient adherence to treatment regimens.
Regional market distribution reveals that North America and Europe are the leading markets for Lurasidone. This dominance is primarily driven by factors such as well-established healthcare systems, high diagnosis rates of mental health disorders, and favorable reimbursement policies. In these regions, key market dynamics include the presence of major pharmaceutical companies investing in research and development of new antipsychotic drugs, creating a competitive landscape for Lurasidone.
Despite its growth potential, the Lurasidone market faces challenges such as generic competition and regulatory hurdles. The entry of generic versions of Lurasidone can lead to price erosion, impacting the revenue of branded products. Moreover, stringent regulations regarding the approval and marketing of antipsychotic medications pose challenges for market expansion.
In conclusion, the market for Lurasidone is poised for steady growth driven by increasing demand for mental health treatments. To capitalize on this growth, pharmaceutical companies need to focus on innovation, market expansion in emerging economies, and strategic partnerships to overcome challenges and maintain a competitive edge in the market.
This report provides a deep insight into the global Lurasidone market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lurasidone Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lurasidone market in any manner.
Global Lurasidone Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Angelini Holding S.p.A.
Sumitomo Dainippon Pharma Co.
Ltd.
RemedyRepack，Inc.
Bushu Pharmaceutical
LTD.
Zhejiang Hisun Pharmaceutical Co.
Ltd.
Healthcare Pharmaceuticals Limited
Square Pharmaceuticals Ltd.
Incepta Pharmaceuticals Ltd.
Market Segmentation (by Type)
20mg/tablet
40mg/tablet
60mg/tablet
80mg/tablet
120mg/tablet
Market Segmentation (by Application)
Hospital
Psychological Clinic
Others
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Lurasidone Market
• Overview of the regional outlook of the Lurasidone Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lurasidone Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
